SWK Holdings monetizes royalty portfolio for $51.3M; plans dividend

SWK Holdings Corp

ANI Pharmaceuticals exercised buyout of Iluvien royalty for ~$17.3M.
Definitive agreement with Soleus Capital to sell remaining performing royalties for ~$34.0M.
Total $51.3M represents ~$1.0M gain over book value of $50.3M as of Dec 31, 2024.
Soleus transaction expected to close in ~2 weeks; dividend to be declared at closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.